Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart

• Published in: Canadian journal of diabetes Vol. 7; no. 2; pp. 270 - 278
• Main Authors: Tamborlane, William V, Renard, Eric, Wadwa, R Paul, Blevins, Thomas, Jacober, Scott J, Liu, Rong, D'Souza, Deborah N, Rees, Tina M
• Format: Journal Article
• Language: English
• Published: Australia Canadian Diabetes Association 01.03.2015
• Subjects: Adult; Blood Glucose - analysis; Blood Glucose Self-Monitoring; China; Cross-Over Studies; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 2 - drug therapy; Double-Blind Method; Female; Follow-Up Studies; Human health and pathology; Humans; Hyperglycemia - prevention & control; Hypoglycemia - prevention & control; Hypoglycemic Agents - therapeutic use; Insulin Aspart - therapeutic use; Insulin Infusion Systems; Insulin Lispro - therapeutic use; Life Sciences; Male; Postprandial Period; Prognosis; Risk Factors; China; insulin lispro; 关键词：门冬胰岛素，胰岛素输注，赖脯胰岛素，1型糖尿病; Type 1 diabetes; insulin aspart; insulin infusion

The objective of the current study was to assess mean self-monitored blood glucose (SMBG), on day 6 of 6 days of continuous reservoir wear (6D), with insulin lispro (Lis) or insulin aspart (Asp). Two 24-week, randomized trials were conducted in subjects with type 1 diabetes treated by continuous sub...